HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of Cardiology World Conference

September 15-17, 2025 | London, UK

September 15 -17, 2025 | London, UK

Cardio 2025

Yong Xiao Wang, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Yong Xiao Wang, Albany Medical Center, United States

As a common and devastating lung disease, pulmonary hypertension (PH) has a significant rate of both morbidity and death mortality. The current primary interventions for this disease are to use non-specific vasodilators, but patients do not always respond well to these non-specif [....] » Read More

Abraham Teddy Weiss, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Abraham Teddy Weiss, Hadassah University Hospital, Israel

Sudden cardiac death (SCD)-caused by ventricular fibrillation (VF) or standstill-is one of the biggest unmet need in public health: it is unpredictable and occurs in about 1000 persons/day in US and Europe alone with very poor survival. Since survival drops by 10% for every minut [....] » Read More

Y J H J Taverne, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Y J H J Taverne, Erasmus University Medical Center, Netherlands

Cardiac transplantation remains the golden standard for patients with end-stage heart failure when therapeutic approaches and interventions fail to reverse HF progression. Traditionally, hearts are transplanted from brain-death (DBD) donors where the heart is beating at time of p [....] » Read More

Sergey Suchkov, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, Personalized and Precision Medicine (PPM). To achieve the implementation of PPM concept, it is necessary to create a fundamentally new strategy based upon the recogni [....] » Read More

Vaibhav Sharma, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Vaibhav Sharma, St. Louis Heart and Vascular, United States

Background: Endocardial calcification is a rare cardiac condition with limited documented cases, particularly in non-tropical regions. This case report explores an unusual presentation of incidental endomyocardial calcification in a patient without typical predisposing systemic d [....] » Read More

Vaibhav Sharma, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Vaibhav Sharma, St. Louis Heart and Vascular, United States

Background: The cardiovascular implications of marijuana use have gained increasing attention in recent medical literature. While chronic cannabis consumption has been linked to various cardiovascular events, comprehensive documentation of acute myocardial infarction in young adu [....] » Read More

Y J H J Taverne, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Y J H J Taverne, Erasmus University Medical Center, Netherlands

Full midline sternotomy remains the most common incision to correct congenital cardiac defects. Although many minimal invasive programs exist for the adult population worldwide, only a few centers have adopted such a program for the pediatric population. The rise of novel interve [....] » Read More

Ziyu Zhou, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Ziyu Zhou, Erasmus University Medical Center, Netherlands

Congenital heart disease (CHD) continues to pose significant challenges in paediatric cardiology, and Tetralogy of Fallot (ToF) stands out as a condition in need of improved translational models. Traditional in vitro and animal-based systems provide valuable insights but often fa [....] » Read More

Sergey Suchkov, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico

The approaches securing cardiac regeneration in post-infarction period are not available to be practiced. The key problem is the identity of cells be born to generate functionally active cardiac myocytes replenishing those being lost during ischemia. With identification of reside [....] » Read More

Sara Ismail Abdelhalim Ismail, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Sara Ismail Abdelhalim Ismail, Al-Sabah Hospital-Medical, Kuwait

Introduction: Left ventricular (LV) thrombus accounts for up to 10% of cardioembolic strokes. It is frequently observed in patients with a history of myocardial infarction, particularly those with anterior STEMI, reduced left ventricular ejection fraction (LVEF), non-ischemic car [....] » Read More

Zoya Khan, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Zoya Khan, Lakeland Regional Health, United States

Introduction: Anomalous origin of the right coronary artery (RCA) is a rare congenital condition, accounting for less than 1% of coronary anomalies. While many patients are asymptomatic, the anomalous course can lead to myocardial ischemia through external compression rather than [....] » Read More

Michael Sabina, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Michael Sabina, Lakeland Regional Health Medical Center, United States

This presentation will focus on the critical and complex decision-making process involved in managing ventricular septal defects (VSDs) that develop after myocardial infarction (MI). Although VSDs following MI are rare, they represent a life-threatening complication with a high m [....] » Read More

Malik Takreem Ahmad, Speaker at Heart Conferences
Poster Presentation (In-Person)
Malik Takreem Ahmad, King’s College London, United Kingdom

Background: Rheumatic heart disease (RHD) is a leading cause of valvular heart disease globally, particularly in low- and middle-income countries, where it significantly contributes to non-obstetric maternal morbidity and mortality. Echocardiography has emerged as a promising too [....] » Read More

Raghul Ganesapandi, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Raghul Ganesapandi, Director Cath Lab J.P Heart Institute, India

Background: Age is a key factor influencing outcomes for patients with acute coronary syndromes (ACS). However, in community practice, there is a noticeably lower utilization of cardiovascular medications and invasive treatments among elderly patients with ACS, even though t [....] » Read More

Cuong Nguyen Manh, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Cuong Nguyen Manh, Can Tho Stroke International Services, Vietnam

Introduction: Robotic-assisted percutaneous coronary intervention (R-PCI) has shown safety and efficacy, but direct comparisons with manual PCI (M-PCI) are limited. Objective: To compare the outcomes and safety of R-PCI using the CorPath GRX system versus M-PCI in pa [....] » Read More

Nabihah Hussaini, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Nabihah Hussaini, University Hospital Lewisham, United Kingdom

Presentation: A 54-year-old woman was referred with an 8-week history of pressure sensations over the chest and epigastrium unrelated to exertion. She presented to the Emergency Department 4 weeks prior but self-discharged against medical advice due to the long wait time. Diag [....] » Read More

Robert J Chilton, Speaker at Cardiology Conferences
Keynote Presentation (Virtual)
Robert J Chilton, University of Texas Health Science Center San Antonio, United States

Finerenone is a non-steroidal mineralocorticoid receptor antagonist (MRA) designed to manage heart failure, especially in patients with chronic kidney disease (CKD) and type 2 diabetes. Heart failure and CKD frequently co-exist, and the combination poses a particularly high cardi [....] » Read More

Syed Raza, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Syed Raza, Awali Hospital, Bahrain

Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. The primary prevention of CVD is dependent upon the ability to identify high-risk individuals long before the development of overt events. This highlights the need for accurate risk stratificatio [....] » Read More

Omar Sami Abdelhai, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Omar Sami Abdelhai, Henry Ford Health, United States

Background: Left ventricular systolic function is not well-characterized in patients with low high-sensitivity cardiac troponin I (hs-cTnI) evaluated in the Emergency Department (ED). Methods: A stepped-wedge randomized trial conducted from July 2020 to March 2021, involved pa [....] » Read More

Randa Elzein, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Randa Elzein, SUNY Upstate Medical University, United States

Introduction: Atrial Fibrillation (AF) is the most common sustained arrhythmia, and its incidence and prevalence are growing in the United States and worldwide. Catheter ablation was successful in decreasing recurrence of AF by 48% and symptomatic AF by 51% compared with drug the [....] » Read More

Agustin Joison, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Agustin Joison, Cordoba Catholic University, Argentina

Introduccion: Diabetes is a major comorbidity for heart failure and is more common than myocardial infarction with an increased risk of more than 50% in cardiovascular disease. Recently, high-sensitivity cardiac troponin T (hs-cTnT)  has been shown to be associated with the [....] » Read More

Yasser Mohammed Hassanain Elsayed, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt

Aim of the study: The study is aimed to clear the cycle effect of fear or anxiety and calm or reassurance on electrocardiographic ST-segment depression in patients present with angina with possible coronary artery spasms. Background: Anxiety and fear have undoubted hazardous e [....] » Read More

Fatima Sajid, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Fatima Sajid, King Edward Medical University, Pakistan

This retrospective cohort study aimed to compare the one-year outcomes of anterior-posterior (AP) and anterior-lateral (AL) methods of cardioversion for atrial fibrillation (AF). A total of 2168 patients were included, with 1125 patients in the AP cardioversion group (Group 1) an [....] » Read More

Kanran Wang, Speaker at Heart Conferences
Oral Presentation (Virtual)
Kanran Wang, Chongqing University Cancer Hospital, China

Background: This study aimed to examine the longitudinal association between the triglyceride glucose-body mass index (TyG-BMI) index and memory-related diseases (MDs) among Chinese adults. Methods: Data were obtained from the China Health and Retirement Longitudinal Study (CH [....] » Read More

Mersal Samimi, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Mersal Samimi, University of California, United States

Background: While hyperthyroidism and atrial fibrillation has been extensively studied, in patients with atrial fibrillation, much remains unexplored regarding the presence of concurrent subclinical hypothyroidism and in-hospital outcomes. We will explore the national inpatient s [....] » Read More

Mersal Samimi, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Mersal Samimi, University of California, United States

Introduction: Constrictive pericarditis is a rare disease where calcification of the pericardium leads to restricted diastolic filling of the heart. Due to its non-specific symptoms, such as dyspnea with exertion, peripheral edema, and chest discomfort, it can mimic many primary [....] » Read More

Abhishek Kamath, Speaker at Cardiovascular Conference
Poster Presentation (Virtual)
Abhishek Kamath, University of Alabama at Birmingham, United States

Background: Stress-induced cardiomyopathy, also known as Takotsubo syndrome (TS), presents as acute left ventricular systolic dysfunction, typically with non-obstructed coronary arteries and regional dyskinesia, and is catecholamine mediated. TS is associated with significant mor [....] » Read More

Ayushi Mohan, Speaker at Heart Conferences
Poster Presentation (Virtual)
Ayushi Mohan, New York Medical College at St. Michael's Medical Center, United States

Introduction: Current treatment recommendations for secondary mitral regurgitation (MR) include transcatheter edge-to-edge repair (TEER) and mitral valve surgery. Surgical repair (SR) has been the traditional approach but TEER has emerged as a less invasive alternative. Currently [....] » Read More

Ayushi Mohan, Speaker at Heart Conferences
Poster Presentation (Virtual)
Ayushi Mohan, New York Medical College at St. Michael's Medical Center, United States

Introduction: Tricuspid regurgitation (TR) is a common valvular disease linked to significant morbidity and mortality. It has a well-documented independent prognostic impact. Surgical repair (SR) is a recognized option for severe or progressive TR, or as an adjunct to mitral valv [....] » Read More

Mohammad Ali Darbandi, Speaker at Heart Conferences
Poster Presentation (Virtual)
Mohammad Ali Darbandi, Nafas Pharmed Pharmaceutical Company, Iran (Islamic Republic of)

Spironolactone belongs to the second class of the bio pharmacy classification system (BCS). All of the drugs, which are classified in this group, suffer from the solubility as the major problem. For this reason, application of any different technique which increases the solubilit [....] » Read More

Will be updated soon......
Watsapp